Immunotherapy as first treatment for advanced stage IV cancers
Part of Cancer clinical trials.
This study looks at whether immune checkpoint inhibitors given as the first treatment work well and are safe for people with advanced (stage IV) solid tumors. You might qualify if you can take study treatment reliably and your cancer type and health match the study rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign the consent form and follow the study plan
- Your cancer is confirmed by biopsy/pathology (tissue diagnosis)
- Your cancer is stage IV (as defined for lung cancer in the IASLC staging system)
- You are 18 to 75 years old, and expected to live more than 3 months
- Your body is healthy enough for treatment (heart, liver, and kidneys not severely impaired)
- No major reason you cannot take immune checkpoint inhibitors (immunotherapy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well immunotherapy (a type of cancer treatment that helps your immune system attack cancer cells) works for people with various types of cancer. You may join if you are already planning to receive this treatment, and the study will track your outcomes to help improve future care.
This study tests a new treatment that uses your own immune cells, called TIL, to fight advanced solid tumors. It may be given alone or with another drug that helps the immune system attack cancer. The goal is to see if this treatment is safe and effective for people who have already tried other treatments.
This study uses blood and tumor samples to find markers that predict whether immunotherapy will work for people with stage IV cancer. The goal is to better match treatments to patients.
This study looks at how well immunotherapy works as the first treatment for people with advanced non-small cell lung cancer that has a low PD-L1 level. It aims to understand the benefits and side effects in this specific group of patients.
This trial tests a new immune cell therapy for people with advanced solid tumors (lung, liver, colorectal, or breast cancer). It aims to use your own immune cells to fight the cancer, and might help if standard treatments have stopped working.
This trial tests a new therapy that uses your own immune cells (called TILs) to fight advanced solid tumors. The cells are taken from a tumor, grown in a lab, and then given back to you, potentially helping your body attack the cancer.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.